- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antiherpetic drugs: a potential way to prevent Alzheimer’s disease? ; volume:14 ; number:1 ; day:7 ; month:1 ; year:2022 ; pages:1-11 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (7.1.2022), 1-11, 12.2022
- Urheber
-
Linard, Morgane
Bezin, Julien
Hucteau, Emilie
Joly, Pierre
Garrigue, Isabelle
Dartigues, Jean-François
Pariente, Antoine
Helmer, Catherine
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-021-00950-0
- URN
-
urn:nbn:de:101:1-2022042411160103439056
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Linard, Morgane
- Bezin, Julien
- Hucteau, Emilie
- Joly, Pierre
- Garrigue, Isabelle
- Dartigues, Jean-François
- Pariente, Antoine
- Helmer, Catherine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Volatile terpenoids as potential drug leads in Alzheimer’s disease
The Alzheimer’s disease drug development landscape
Alzheimer’s Disease Drug Development Pipeline 2020
Advances in Alzheimer’s Disease Drug Development
Geroscience and Alzheimer’s Disease Drug Development
Alzheimer’s Disease (AD) Detect & Prevent : presymptomatic AD detection and prevention
Advances in Drug Therapy for Alzheimer’s Disease
Melatonin: A potential nighttime guardian against Alzheimer’s
Non-drug Therapies for Alzheimer’s Disease: A Review
Drug candidates in clinical trials for Alzheimer’s disease
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Single-cell-led drug repurposing for Alzheimer’s disease
Volatile terpenoids as potential drug leads in Alzheimer’s disease
The Alzheimer’s disease drug development landscape
Alzheimer’s Disease Drug Development Pipeline 2020
Advances in Alzheimer’s Disease Drug Development
Geroscience and Alzheimer’s Disease Drug Development
Alzheimer’s Disease (AD) Detect & Prevent : presymptomatic AD detection and prevention
Advances in Drug Therapy for Alzheimer’s Disease
Melatonin: A potential nighttime guardian against Alzheimer’s
Non-drug Therapies for Alzheimer’s Disease: A Review
Drug candidates in clinical trials for Alzheimer’s disease
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Single-cell-led drug repurposing for Alzheimer’s disease
Volatile terpenoids as potential drug leads in Alzheimer’s disease
The Alzheimer’s disease drug development landscape
Alzheimer’s Disease Drug Development Pipeline 2020
Advances in Alzheimer’s Disease Drug Development
Geroscience and Alzheimer’s Disease Drug Development
Alzheimer’s Disease (AD) Detect & Prevent : presymptomatic AD detection and prevention
Advances in Drug Therapy for Alzheimer’s Disease
Melatonin: A potential nighttime guardian against Alzheimer’s
Non-drug Therapies for Alzheimer’s Disease: A Review
Drug candidates in clinical trials for Alzheimer’s disease
Heterogeneity of Alzheimer’s disease: consequence for drug trials?